Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06636539 · ClinicalTrials.gov registry record · NA
Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device
A NA study of Breast Screening, sponsored by Hologic.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT06636539 is a NA study of Breast Screening that is actively recruiting participants, run by Hologic. The registered enrollment target is 75 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06636539, a NA study of Breast Screening, is actively recruiting participants, sponsored by Hologic.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormality on a screening or diagnostic mammogram who are indicated for a diagnostic exam or a biopsy procedure.
Conditions Studied
Interventions
- DEVICE CEM Software in New Mammography Device
Study Locations (2)
Texas
- Solis Mammography Memorial Village - Houston
Virginia
- Washington Radiology Sterling - Sterling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06636539
The ClinicalTrials.gov registry entry for NCT06636539 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Screening appearing as the primary indexed condition, and to 1 intervention - of which CEM Software in New Mammography Device is the first listed.
NCT06636539 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Virginia.
Frequently Asked Questions
What is clinical trial NCT06636539 about?
NCT06636539 is a clinical study titled "Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device". This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormalit...
What is the current status of trial NCT06636539?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2024-10-14. Estimated completion is 2026-03-31.
What conditions does trial NCT06636539 study?
This clinical trial studies the following conditions: Breast Screening.
What interventions are being tested in trial NCT06636539?
The interventions under investigation include: CEM Software in New Mammography Device (DEVICE).
Who is sponsoring clinical trial NCT06636539?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06636539 being conducted?
This trial has 2 study locations across Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.